ETF Daily News9d
Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
Trinity Biotech has a one year low of $0.74 and a ... sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus ...
ETF Daily News19d
Trinity Biotech (TRIB) Expected to Announce Quarterly Earnings on Wednesday
3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Trinity Biotech plc acquires ... diseases consisting of syphilis and herpes; SARS-CoV-2; and ...
Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, ...
Nasdaq1mon
Trinity Biotech plc Secures Additional Liquidity Through Amended Agreements with Perceptive Advisors to Support Comprehensive Transformation Plan
Trinity Biotech plc announced revised agreements with its primary lender, Perceptive Advisors, to improve its financial position as the company implements its Comprehensive Transformation Plan and ...
Business Insider18d
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...